News

Sparrow Cleared to Start Phase 2 Trial of SPI-62 Early Next Year

Sparrow Pharmaceuticals is gearing up for the start of a Phase 2 trial that will assess the safety and effectiveness of the company’s experimental medicine SPI-62 in people with Cushing’s disease. The U.S. Food and Drug Administration has cleared Sparrow’s investigational new drug application (IND), giving the company…

Fast-progressing Case Highlights Need for Good Management

The case of an elderly woman who may have developed Cushing’s syndrome due to a hormone-producing lump in her lungs highlights the need for a timely and “multidisciplinary approach in [the] diagnosis and management” of hypercortisolism disorders, according to a new report. This patient’s signs and symptoms progressed…

Test Found Useful for Diagnosing Cushing’s During Pregnancy

The desmopressin stimulation test can be useful to diagnose Cushing’s during pregnancy, a time when its identification may be particularly challenging due to the hormonal changes these women experience, a new case report says. The report, “Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Disease,” was published…

2-test Combo Reaches 100% Diagnostic Accuracy

A combination of two easily performed tests reached 100% accuracy for diagnosing Cushing’s disease in people with an initial negative result from an MRI scan, or who had a a small tumor in their brain’s pituitary gland, a study reports. The study, “Indication to dynamic and…

Rare Disease Groups in US Join in Plea for Care Across State Lines

Over 230 national organizations signed a letter urging all 50 U.S. state governors to “maintain and expand” flexibility with licensure requirements for the duration of the COVID-19 pandemic to ease access to care. During the pandemic, governors used emergency authority to waive certain state licensure requirements, giving healthcare providers…